Target Site Pharmacokinetics of Doripenem at Steady State in Intubated Intensive Care Patients.
Phase of Trial: Phase IV
Latest Information Update: 27 Feb 2017
At a glance
- Drugs Doripenem (Primary)
- Indications Bacterial infections
- Focus Pharmacokinetics
- Acronyms Dori-MD-ICU
- 18 Oct 2014 Status changed from recruiting to discontinued, according to European Clinical Trials Database record.
- 18 Oct 2014 Planned number of patients changed from 16 to 20, according to European Clinical Trials Database record.
- 06 Sep 2011 Planned end date (Jul 2013) added as reported by ClinicalTrials.gov.